A wakeful hypometabolic state may be induced by simple, non-cultic mental techniques or by traditional meditational practices. The hypometabolic state seems to represent an integrated hypothalamic response (“relaxation response”) which is consistent with a state of decreased sympathetic-nervous-system activity. A prospective investigation was designed to test whether regular elicitation of the relaxation response might lower blood-pressures in hypertensive patients who were maintained on constant antihypertensive therapy. Fourteen people were investigated. During the control period of 5.6 weeks, blood-pressures did not change significantly from day to day and averaged 145.6 mm.Hg systolic and 91.9 mm.Hg diastolic. During the experimental period of 20 weeks, systolic blood-pressures decreased to 135.0 mm.Hg (P < 0.01) and diastolic blood-pressures fell to 87.0 mm.Hg (P < 0.05). The regular elicitation of the relaxation response may, therefore, have usefulness in the management of hypertensive subjects who are already on drug therapy. The use of the relaxation response may influence the economics of the therapy of hypertension since it is practised at no cost other than time.
Decreased Blood-Pressure in Pharmacologically Treated Hypertensive Patients Who Regularly Elicited the Relaxation Response
Publication
The Lancet
Volume 303, Issue 7852, P289-291
Abstract
Web and Email Links
Related Listings
Journal
Science
Sympathetic nervous system activity was assessed in experimental and control subjects who were exposed to graded orthostatic and isometric stress during monthly hospital visits. After the first session, the experimental subjects practiced a technique that elicited the relaxation response. Their concentrations of plasma norepinephrine during subsequent graded stresses were significantly higher. No such changes were noted in the control group. These results were then replicated in the c […]
Journal
Journal Alternative and Complementary Medicine
Objective: Mind–body practices that elicit the relaxation response (RR) have been demonstrated to reduce blood pressure (BP) in essential hypertension (HTN) and may be an adjunct to antihypertensive drug therapy. However, the molecular mechanisms by which the RR reduces BP remain undefined. Design: Genomic determinants associated with responsiveness to an 8-week RR-based mind–body intervention for lowering HTN in 13 stage 1 hypertensive patients classified as BP responders and 11 as n […]
Journal
Journal of Cardiovascular Nursing
Hypertension is one of the leading health problems in the United States. It is commonly accepted that as many as 60 million Americans have hypertension, with the majority (>70%) having mild elevations (diastolic pressure range, 90-104 mm Hg). The treatment of hypertension accounts for more office visits to health care providers and more treatment than any other medical diagnosis. A 1980 National Institutes of Health survey showed that about 2% of visits to health care providers wer […]